213 related articles for article (PubMed ID: 21779188)
1. Microangiopathic hemolytic anemia as the first manifestation of metastatic signet ring cell carcinoma of unknown origin: a case report and review of literature.
Shin SY; Park H; Chae SW; Woo HY
Korean J Lab Med; 2011 Jul; 31(3):157-61. PubMed ID: 21779188
[TBL] [Abstract][Full Text] [Related]
2. Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature.
Arkenau HT; Müssig O; Buhr T; Jend HH; Porschen R
Z Gastroenterol; 2005 Aug; 43(8):719-22. PubMed ID: 16088769
[TBL] [Abstract][Full Text] [Related]
3. Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study.
Lam R; Tarangelo N; Wang R; Horibe M; Grimshaw AA; Jain D; Haffar S; Bazerbachi F; Kunz PL; Li DK
Oncologist; 2022 Sep; 27(9):751-759. PubMed ID: 35589098
[TBL] [Abstract][Full Text] [Related]
4. Microangiopathic hemolytic anemia caused by a signet-ring cell carcinoma of the intrahepatic bile duct.
Younes R; Ponzo P; Marzano A
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):431-434. PubMed ID: 28927252
[TBL] [Abstract][Full Text] [Related]
5. A Metastatic Signet Ring Cell Carcinoma Presented as Acquired Thrombotic Thrombocytopenic Purpura: A Case Report.
Eisa N; Nasef K; Emarah Z; Fattah MMA; Shamaa S
J Hematol; 2018 May; 7(2):72-75. PubMed ID: 32300416
[TBL] [Abstract][Full Text] [Related]
6. A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura.
Malkan UY; Albayrak M; Ozturk HB; Reis Aras M; Saglam B; Dogan K
Case Rep Oncol; 2020; 13(3):1368-1372. PubMed ID: 33442357
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic plasma exchange in gastric signet ring cell carcinoma presenting as microangiopathic hemolytic anemia: A rare case report.
Candar O; Ekinci O; Merter M; Aslan M; Aras I
J Clin Apher; 2022 Dec; 37(6):606-610. PubMed ID: 36125111
[TBL] [Abstract][Full Text] [Related]
8. [Hemorrhagic diathesis as initial symptom of stomach carcinoma].
Dempke W; von Poblozki A; Kellner O; Wolf HH; Schmoll HJ
Wien Klin Wochenschr; 2000 Dec; 112(24):1053-8. PubMed ID: 11204317
[TBL] [Abstract][Full Text] [Related]
9. Metastatic signet ring gastric adenocarcinoma presenting with microangiopathic hemolytic anemia.
Ali N; Kamran N; Adil S; Pervez S
Indian J Gastroenterol; 2007; 26(4):185-6. PubMed ID: 17986749
[TBL] [Abstract][Full Text] [Related]
10. Signet ring cell carcinoma metastasis in the bone marrow accompanied by cancer related thrombotic microangiopathy as a first presentation.
Baysal M; Alkış N; Tosun S
Niger J Clin Pract; 2022 Feb; 25(2):211-214. PubMed ID: 35170451
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safe use of modified FOLFOX-6 for metastatic gastric cancer with signet ring cell components complicated by disseminated intravascular coagulation and diffuse bone marrow carcinomatosis.
Ferrand FR; Gontier E; Guymar S; Fagot T; Ceccaldi B; Malfuson JV; de Revel T
Onkologie; 2012; 35(3):118-20. PubMed ID: 22414976
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous presentation of hairy cell leukemia and metastatic signet ring carcinoma of the stomach diagnosed by bone marrow biopsy.
Perunicic-Jovanovic M; Djunic I; Tomin D; Terzic T; Jakovic L; Sokic A; Gotic M
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):279-82. PubMed ID: 21475041
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic thrombocytopenic purpura as the first manifestation of metastatic adenocarcinoma in a young woman.
Kadikoylu G; Barutca S; Tataroglu C; Kafkas S; Erpek H; Meydan N; Yavasoglu I; Bolaman Z
Transfus Apher Sci; 2010 Feb; 42(1):39-42. PubMed ID: 19926523
[TBL] [Abstract][Full Text] [Related]
14. [Severe microangiopathic hemolytic anemia as first manifestation of a CUP syndrome. Rapid hematologic remission under polychemotherapy].
Abdel Samie A; Sandritter B; Theilmann L
Med Klin (Munich); 2004 Mar; 99(3):148-53. PubMed ID: 15024487
[TBL] [Abstract][Full Text] [Related]
15. Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases.
Lechner K; Obermeier HL
Medicine (Baltimore); 2012 Jul; 91(4):195-205. PubMed ID: 22732949
[TBL] [Abstract][Full Text] [Related]
16. A rare case of concurrent signet-ring carcinoma of breast and microangiopathic hemolytic anemia.
Lara K; Bae E; Park H; Hussain F
J Surg Case Rep; 2016 Sep; 2016(9):. PubMed ID: 27587305
[TBL] [Abstract][Full Text] [Related]
17. Microangiopathic hemolytic anemia and leukoerythroblastic blood film heralding bone marrow metastatic gastroesophageal adenocarcinoma.
Rauh MJ; Al Habeeb A; Chang H
Pathol Res Pract; 2011 Feb; 207(2):121-3. PubMed ID: 20691546
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura and bone marrow necrosis associated with disseminated gastric cancer.
Otrock ZK; Taher AT; Makarem JA; Kattar MM; Nsouli G; Shamseddine AI
Dig Dis Sci; 2007 Jun; 52(6):1589-91. PubMed ID: 17436106
[No Abstract] [Full Text] [Related]
19. Microangiopathic Hemolytic Anemia Due to Malignancy in Pregnancy.
Happe SK; Zofkie AC; Nelson DB
Obstet Gynecol; 2016 Dec; 128(6):1437-1440. PubMed ID: 27824770
[TBL] [Abstract][Full Text] [Related]
20. Cancer-related thrombotic microangiopathy and disseminated intravascular coagulation in a patient with bone marrow carcinomatosis of unknown primary origin: A case report.
Manabe M; Inano N; Hagiwara Y; Sogabe N; Nanno S; Mazaki T; Koh KR
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2036. PubMed ID: 38517451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]